|
|
||||||||
1 Pulmonary Rehabilitation Centre Hornerheide, Horn, and 3 Dept of Respiratory Medicine, and 4 Care and Public Health Research Institute (CAPHRI), University Hospital Maastricht, Maastricht, and 2 Heymans Institute, University of Groningen, Groningen, The Netherlands.
CORRESPONDENCE: E. J. Wagena, A Plein 10, 8011 TK Zwolle, The Netherlands. Fax: 31 294410571. E-mail: edwin.wagena@solvay.com
Keywords: Chronic obstructive pulmonary disease, depression, psychological distress, psychoneuroticism, Symptom Checklist-90-Revised
Received: January 26, 2004
Accepted February 2, 2005
This study was designed to assess the level of psychological distress in a heterogeneous group of patients with chronic obstructive pulmonary disease (COPD), and compare them with the general population and psychiatric outpatients.
A total of 118 patients with COPD, a random sample of 500 subjects from the general population and 500 psychiatric outpatients participated in this study. The Dutch version of the Symptom Checklist-90-Revised was used to assess general psychological distress.
The sample of patients with COPD experienced significantly more psychological distress than the general population and significantly less than psychiatric outpatients. Furthermore, no significant association was found between the severity of the pulmonary disease and the level of psychological distress, although patients with severe or very severe COPD appeared to be at increased risk of depression. Lastly, the pattern of psychological complaints seems comparable in depressed patients with COPD and psychiatric outpatients. Once patients with COPD report suffering from depressive symptoms, the level of distress seems to increase to that found in psychiatric outpatients.
In conclusion, in clinical settings in which psychological complaints are not routinely assessed, the Beck Depression Inventory and Symptom Checklist-90-Revised are very useful for drawing attention to depression and psychological distress.
This article has been cited by other articles:
![]() |
E. M. Clini and N. Ambrosino Nonpharmacological treatment and relief of symptoms in COPD Eur. Respir. J., July 1, 2008; 32(1): 218 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Watz, B. Waschki, C. Boehme, M. Claussen, T. Meyer, and H. Magnussen Extrapulmonary Effects of Chronic Obstructive Pulmonary Disease on Physical Activity: A Cross-sectional Study Am. J. Respir. Crit. Care Med., April 1, 2008; 177(7): 743 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hill, R. Geist, R. S. Goldstein, and Y. Lacasse Anxiety and depression in end-stage COPD Eur. Respir. J., March 1, 2008; 31(3): 667 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Laurin, K. L. Lavoie, S. L. Bacon, G. Dupuis, G. Lacoste, A. Cartier, and M. Labrecque Sex Differences in the Prevalence of Psychiatric Disorders and Psychological Distress in Patients With COPD Chest, July 1, 2007; 132(1): 148 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A Cleland, A. J Lee, and S. Hall Associations of depression and anxiety with gender, age, health-related quality of life and symptoms in primary care COPD patients Fam. Pract., June 1, 2007; 24(3): 217 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Wagena, P. G. Knipschild, M. J. H. Huibers, E. F. M. Wouters, and C. P. van Schayck Efficacy of Bupropion and Nortriptyline for Smoking Cessation Among People at Risk for or With Chronic Obstructive Pulmonary Disease Arch Intern Med, October 24, 2005; 165(19): 2286 - 2292. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |